Management of Severe Immunocompromise in HIV Patients

Classification and Clinical Implications

A CD4 count of 123 cells/mm³ is below the critical threshold of 200 cells/mm³, which defines severe immunodeficiency and is one of the CDC criteria for AIDS diagnosis 1
Patients with CD4 counts <200 cells/mm³ are classified as having advanced HIV disease (CDC Category 3) regardless of clinical symptoms 2, 1
This level of immunosuppression significantly increases the risk for opportunistic infections and AIDS-defining illnesses 3
The CDC recommends that patients with CD4 <200 cells/mm³ are at high risk for Pneumocystis jirovecii pneumonia (PCP), requiring prophylaxis 3
The CDC also recommends that patients with CD4 <150 cells/mm³ are at increased risk for toxoplasmosis, histoplasmosis, and cryptococcosis 3
The CDC states that patients with CD4 <100 cells/mm³ are at risk threshold for disseminated fungal infections and cerebral toxoplasmosis prophylaxis 3
The CDC notes that patients with CD4 <50 cells/mm³ are at risk for disseminated Mycobacterium avium complex (MAC) 3

Lymphoma (primary CNS lymphoma or systemic lymphoma with CNS involvement) is a common AIDS-defining malignancy that should be considered in severely immunocompromised patients with mediastinal mass and brain lesions 4
Toxoplasmosis is a typical infection with CD4 <150 cells/mm³ causing ring-enhancing brain lesions, according to the Infectious Diseases Society of America 3
Tuberculosis can occur at any CD4 level but risk increases significantly with CD4 <200 cells/mm³, as stated by the World Health Organization 3
Cryptococcosis typically occurs with CD4 <100 cells/mm³, according to the Centers for Disease Control and Prevention 3
Progressive multifocal leukoencephalopathy (PML) is a JC virus infection in severely immunocompromised patients that should be considered, as noted by the Infectious Diseases Society of America 4

Patients with CD4 <200 cells/mm³ have higher morbidity and mortality rates with surgical interventions compared to those with CD4 >200 cells/mm³, as reported by the World Journal of Emergency Surgery 5, 2
The mortality rate for emergency surgery in AIDS patients can reach 30-45%, according to the World Journal of Emergency Surgery 5
Postoperative infectious complications are significantly more common in patients with CD4 <200 cells/mm³, as stated by the World Journal of Emergency Surgery 5

Live vaccines are contraindicated at this level of immunosuppression, as recommended by the Infectious Diseases Society of America 6, 7, 8
Yellow fever vaccine should not be administered (only considered if CD4 ≥200 cells/mm³), according to the Centers for Disease Control and Prevention 6, 8
Mandatory prophylaxis required: Trimethoprim-sulfamethoxazole for PCP prevention, as recommended by the Centers for Disease Control and Prevention 3

Immediate initiation or optimization of antiretroviral therapy is critical, as stated by the World Health Organization 2
ART should be continued perioperatively whenever possible and resumed as soon as feasible if interrupted, according to the World Health Organization 2

Do not delay diagnostic workup - severely immunocompromised patients may have atypical or subtle presentations of serious infections, as noted by the Infectious Diseases Society of America 2, 4
Laboratory markers may not reflect disease severity - inflammatory responses are blunted at this CD4 level, according to the World Journal of Emergency Surgery 2
Multiple concurrent opportunistic infections are possible - maintain broad differential diagnosis, as recommended by the Infectious Diseases Society of America 4
Contrast-enhanced CT or preferably MRI is essential for adequate evaluation of brain lesions in this population, as stated by the World Journal of Emergency Surgery 2, 4